Concepedia

Melissa A. Ashlock

MA

Statistics

Publications

19

Citations

4.6K

H-Index

16

Active since

1986

Affiliations

Cystic Fibrosis Foundation(Current)

Vertex Pharmaceuticals (United States)

Case Western Reserve University

University of Alabama at Birmingham

University of Pittsburgh

Melissa A. Ashlock is an author at Cystic Fibrosis Foundation specializing in cystic fibrosis, medicine, and cftr gene mutations.

Publications per year

1986–2020

19

Publications

19

Rescue of CF airway epithelial cell function in vitro by a CFTR potentiator, VX-770

Fredrick Van Goor, Sabine Hadidaꝉ, Peter D. J. Grootenhuis et al. · Proceedings of the National Academy of Sciences · 2009 · 1.2K citations · Full text

, , +17

Correction of the F508del-CFTR protein processing defect in vitro by the investigational drug VX-809

Fredrick Van Goor, Sabine Hadidaꝉ, Peter D. J. Grootenhuis et al. · Proceedings of the National Academy of Sciences · 2011 · 1.1K citations · Full text

, , +13

Effect of VX-770 in Persons with Cystic Fibrosis and the G551D- <i>CFTR</i> Mutation

Frank J. Accurso, Steven M. Rowe, John P. Clancy et al. · New England Journal of Medicine · 2010 · 802 citations · Full text

, , +12

Results of a phase IIa study of VX-809, an investigational CFTR corrector compound, in subjects with cystic fibrosis homozygous for the <i>F508del-CFTR</i> mutation

John P. Clancy, Steven M. Rowe, Frank J. Accurso et al. · Thorax · 2011 · 496 citations · Full text

, , +16

Replacement of the anterior cruciate ligament using a patellar tendon allograft. An experimental study.

Steven P. Arnoczky, Russell F. Warren, Melissa A. Ashlock · Journal of Bone and Joint Surgery · 1986 · 309 citations

, , +14

1–5 of 19